- Home
- HWKN vs PTGX Comparison
HWKN vs PTGX Comparison
Compare HWKN & PTGX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HWKN
- PTGX
- Stock Information
- Founded
- HWKN 1938
- PTGX 2006
- Country
- HWKN United States
- PTGX United States
- Employees
- HWKN N/A
- PTGX N/A
- Industry
- HWKN Specialty Chemicals
- PTGX Biotechnology: Pharmaceutical Preparations
- Sector
- HWKN Consumer Discretionary
- PTGX Health Care
- Exchange
- HWKN Nasdaq
- PTGX Nasdaq
- Market Cap
- HWKN 2.4B
- PTGX 2.8B
- IPO Year
- HWKN N/A
- PTGX 2016
- Fundamental
- Price
- HWKN $123.60
- PTGX $41.11
- Analyst Decision
- HWKN Hold
- PTGX Strong Buy
- Analyst Count
- HWKN 1
- PTGX 7
- Target Price
- HWKN $122.00
- PTGX $53.57
- AVG Volume (30 Days)
- HWKN 136.9K
- PTGX 529.7K
- Earning Date
- HWKN 10-30-2024
- PTGX 11-07-2024
- Dividend Yield
- HWKN 0.58%
- PTGX N/A
- EPS Growth
- HWKN 18.72
- PTGX N/A
- EPS
- HWKN 3.91
- PTGX 2.68
- Revenue
- HWKN $934,424,000.00
- PTGX $323,795,000.00
- Revenue This Year
- HWKN $5.61
- PTGX $396.93
- Revenue Next Year
- HWKN $7.54
- PTGX N/A
- P/E Ratio
- HWKN $31.64
- PTGX $15.32
- Revenue Growth
- HWKN N/A
- PTGX 125.73
- 52 Week Low
- HWKN $54.44
- PTGX $16.01
- 52 Week High
- HWKN $135.61
- PTGX $48.89
- Technical
- Relative Strength Index (RSI)
- HWKN 54.00
- PTGX 31.67
- Support Level
- HWKN $122.56
- PTGX $45.23
- Resistance Level
- HWKN $128.93
- PTGX $48.86
- Average True Range (ATR)
- HWKN 4.74
- PTGX 2.16
- MACD
- HWKN 1.25
- PTGX -0.79
- Stochastic Oscillator
- HWKN 82.36
- PTGX 17.99
About HWKN Hawkins Inc.
Hawkins Inc manufactures and sells a variety of chemicals and ingredients. The firm organizes itself into three segments based on the product type. The industrial segment, which generates the majority of revenue, sells private label bleach, caustic soda, sulfuric acid, hydrochloric acid, phosphoric acid, potassium hydroxide, and aqua ammonia. The water treatment segment sells chemicals and equipment used to treat potable water, municipal and industrial wastewater, industrial process water, and non-residential swimming pool water. The health and nutrition segment sells ingredients to food, beverage, personal care, and dietary supplement producers.
About PTGX Protagonist Therapeutics Inc.
Protagonist Therapeutics Inc is a clinical-stage biopharmaceutical company having a proprietary technology platform that enables the discovery and development of novel constrained peptide-based drug candidates to address medical needs. Its pipeline products include Rusfertide (PTG-300) and JNJ-2113.